Futura Medical Share Discussion Threads

[petroc] 13/4/2024 13:48

MDI stated: '... Often times we see people talk and boast about what they have and can do but when you move closer to them, you realize they are nothing but empty drums that's why They make loud noise’

He is living testament to the veracity of that!

Here's another one about you, MDI/LBO etc: 'A sharp tongue is not necessarily an indicator of a keen mind.'

[petroc] 13/4/2024 11:57

“A stupid man's report of what a clever man says can never be accurate, because he unconsciously translates what he hears into something he can understand."

[mdi] 13/4/2024 11:23

Stifel admitted one real fact. Which there is now many more pigs with the snouts in the one hit wonder products trough then ever before. With the like of the past failed Futura EPIC product. Who besides a pig currently chowing down on the marketing swill now says all future promises shouldn’t be judged on what they promised in the past decade. Yet continually failed to deliver? Its astonishing to think that the similar Durex delay spray is still selling presumably well on the market. Yet again unlike Futura’s own delay product which was even launched with a large distributor like Ansell. Again failed to attain any of the ‘make believe’ estimates by Futura Medical? And didn’t the CEO say in the most recent presentation they aren’t allowed to make estimates? So where do the brokers get these estimates from?

Stifel in the recent not openly admitted:

‘though a chunk of that will be absorbed by distributors and other middlemen’



January 2014

Futura Medical Epic launch by Ansell in US market

‘The financial terms of the Ansell worldwide licensing agreement are not disclosed but Futura Medical estimates that a 5% share of the global OTC performance-enhancement market would result in royalties of £8-10m per year’

[mdi] 13/4/2024 10:52

And also like the ‘leaky holes’ of how just a non medicated hydroalcoholic medical device gel is supposedly going to be protected from competitors copying it in matter of days via the 510k pathway. If it is indeed to become a sustainable long term brand along the lines of the ‘make believe’ estimates being relied upon to try justify ‘make believe’ broker price targets based on many assumptions and a company valuation over £100m



˜De Novo authorization will also allow subsequent devices of the same type and intended use to come to the market through the 510k pathway, which could enable the devices to get on the market faster’



The vast majority of our FDA 510K clients generally spend in the range of $20,000-$30,000 to have their product or device prepared and reviewed before the actual FDA 510k submission process.

One of the positive sides to seeking a FDA 510K approval for a new medical product, whether tested or untested, is that if there is already a similar FDA approved product being marketed, then the FDA will have to approve any new products that are almost the same as the product that is already FDA 510 K approved and have under gone all required testing, documentation, and registration processes.

So if there is indeed a sustained market for Eroxon Then anyone can just launch a similar non medicated hydroalcoholic gel that will ˜meet criteria for same intended use’. As proven in the Libigel studies and the testosterone gel studies. Has ‘slightly different technology but produces similar end results’. Yes made of similar solvents and also causes evaporative cooling. And is ˜safe and effective’. Yes. the ATD gel technology is already on the market in many gels delivering drugs so wont be any issues getting a non medicated form of hydroalcoholic gel cleared as just a medical device like Eroxon is.

Th only real reason behind the supposed secret ‘commercial sensitivities’ and why distributors apparently don’t want shareholders to know ahead of time where and when they will be launching this one hit wonder before moving on to the next. So the actual question is why are distributors and Haleon so worried ‘endlessly about rivals entering the market’ that they wont let shareholders who own the brand be told anything?

[petroc] 13/4/2024 10:43

Your 'final final' point, takeiteasy?! See you soon!

[mdi] 13/4/2024 10:31

Just like the ‘leaky holes’ of how a non medicated hydroalcoholic gel is apparently going to sustain sales estimates annually with repeat customers to be able to meet abs sustain long term the ‘make believe’ future estimates and price targets? Eventually placebos run out of new markets to hype launch into and dupe new customers so as to prop up the flagging sales from whee they already launched in and the majority eventually realise they were duped into buying an expensive placebo. Even if it does continue to work for some if they are convinced to believe the hype and packaging. Sales of Eroxon (or should I say just accounts receivable) apparently £1.7m in April/May, followed by £1.4m in the following 6 months? Didn’t the CEO even mention one hit wonder products that distributors hype and short term and then move on to the next.



Wellness Investors: Beware The Placebo Trap

Whats the problem with placebos? Placebo effects tend to wear off, and when they do, your customers will drop off. This forces tremendous spending on acquisition since it can cost five times as much to acquire new customers than keep current ones.

Since repeat customers generate more than half of the revenue for a majority of businesses, pretty packaging of a placebo will likely struggle to sustain sales. Perhaps the boom and bust commonly seen with wellness brands isn’t due to the hype cycle, but rather the placebo cycle.

[takeiteasy] 13/4/2024 10:21

As my final final point, when you take away the magic roundabout stuff and have lost all the various arguments you can only resort to -
"well none of anything I say really matters as it's all a placebo anyway" -
so why you worry endlessly about rivals entering the market to also sell a competitive placebo is beyond me - a bucket with so many leaky holes :)

[takeiteasy] 13/4/2024 10:06

That's me done here for a while so I will disappear and wait for the next update from the firm ..

[takeiteasy] 13/4/2024 10:01

Simples, both ED options can take time to get fully effective for entirely different reasons. The issue of it taking time to get spot on needs to become an accepted part of the process.

Eroxon - glands can take several goes to adapt to gel and get full response i.e. asks customers to buy several packets and have multiple goes and persevere and let response build up over time. New packaging may well make this clearer.

Viagra - new customers may need to trial pills with different dose levels to see what is the best balance between ED effect and side effects etc.

So if both need patience to get right do not knock our gel specifically on the timing point is the gist.

[takeiteasy] 13/4/2024 09:00

I joined this recently and I understand if the journey has been 20 years here that is a patient wait.

There is a time to look forward in life and there is a time to look back - imvho we are collectively in look forward mode with new partners and new product suite.

The past is the past is the past.

dyor and no advice

[mdi] 13/4/2024 08:15

More like a good start is to try to look at the dates of previous estimates and claims provided - and if over the many years any of them were met . And if they didn’t. Then the real important fact being provided is a continuous failed track record is pretty much the last shred of credibility about current claims and estimates. That is clearly when being loose with todays facts and claims ‘morph into the magic roundabout of make believe’

‘crikey the CEO would wince at some of the stuff that gets written here - when does being loose with the facts morph into the magic roundabout of make believe’



January 2014

Futura Medical Epic launch by Ansell in US market

‘The financial terms of the Ansell worldwide licensing agreement are not disclosed but Futura Medical estimates that a 5% share of the global OTC performance-enhancement market would result in royalties of £8-10m per year’



March 2021

‘approval could be achieved within 18 months’

[takeiteasy] 12/4/2024 23:56

I am not here to operate some form of editing review system for each post - the posters here will be fully aware of the assertions being made and where there are leaky holes...a good start is to try to look at the dates of facts provided - information from 10-20 years ago removes pretty much the last shred of credibility,ditto trying financial analysis showing next to no knowledge of basic book keeping rules, ditto implying information provided by Haleon does not exist when it does ....

If we ever get a single sensible post I will have no issue in giving an up tick :)

[broomrigg] 12/4/2024 21:19

Hi Petroc, no I'm still out and my sale at c.40p still looks ok. I'm watching closely because after all this time I would hate not to be holding when news comes out on the US roll-out which could come at any time. Good rise at the end there.

[petroc] 12/4/2024 18:41

MDI, your desperate stock bashing is so transparent and fake. You’re as deep as a puddle in a car park. You've only got two brain cells and both of them are fighting for third place.

[mdi] 12/4/2024 18:22

How many times have the FUM BOD yapped on about commercial sensitivity/sensitivities when it suits them? Didn’t the BOD previously disclose a lot more details on the Eroxon deal in Asia? Again when it suited them ahead of asking shareholders for more money. And that was yet another deal that also ultimately over time came to be nothing but ‘make believe’. With rights handed back by another partner with no launch and no real explanation from the BOD on why or what exactly happened with yet another partner again walking away from Eroxon. A product which supposedly shareholders are being repeatedly told has so much ‘potential’?



‘Futura will be entitled to 50% of regional profits from the commercialisation of MED3000 (the "Joint Collaboration")’



March 2021

‘approval could be achieved within 18 months’

[petroc] 12/4/2024 17:49

MDI, you are a filled urn of disappointment, and yet I'm really impressed with your ability to stick to your position regardless of the evidence. It's impossible to underestimate you, you’re the reason tubes of toothpaste have instructions on them.

[mdi] 12/4/2024 17:44

‘when does being loose with the facts morph into the magic roundabout of make believe’



January 2014

Futura Medical
Epic launch by Ansell in US market

‘The financial terms of the Ansell worldwide licensing agreement are not disclosed but Futura Medical estimates that a 5% share of the global OTC performance-enhancement market would result in royalties of £8-10m per year’